EP 0907661 A1 19990414 - METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS
Title (en)
METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS
Title (de)
METHODEN UND ZUSAMMENSETZUNGEN FÜR DIE HEMMUNG VON ALPHA-V-BETA5 VERMITTELTER ANGIOGENESE.
Title (fr)
PROCEDES ET COMPOSITIONS SERVANT A L'INHIBITION DE L'ANGIOGENESE LIEE A LA PRESENCE DE alpha v beta 5
Publication
Application
Priority
- US 9709099 W 19970530
- US 1873396 P 19960531
- US 1586996 P 19960531
Abstract (en)
[origin: WO9745137A1] The present invention describes methods for inhibition of angiogenesis in tissues using vitronectin alpha v beta 3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases using therapeutic compositions containing alpha v beta 3 antagonists.
IPC 1-7
C07K 14/435; C07K 14/705; C07K 14/78; C07K 16/28; A61K 38/16; A61K 38/39; A61K 39/395
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/04 (2006.01); A61K 38/16 (2006.01); A61K 38/48 (2006.01); A61K 39/395 (2006.01); A61P 19/02 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61K 45/00 (2006.01); A61P 35/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07C 279/14 (2006.01); C07C 311/06 (2006.01); C07C 311/10 (2006.01); C07D 263/38 (2006.01); C07K 14/435 (2006.01); C07K 14/705 (2006.01); C07K 14/75 (2006.01); C07K 14/78 (2006.01); C07K 16/28 (2006.01); C07K 19/00 (2006.01); C12N 9/64 (2006.01)
CPC (source: EP KR)
A61K 38/04 (2013.01 - EP); A61K 38/16 (2013.01 - EP); A61K 38/48 (2013.01 - KR); A61K 38/4886 (2013.01 - EP); A61P 7/00 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 27/02 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07C 279/14 (2013.01 - EP); C07C 311/06 (2013.01 - EP); C07C 311/10 (2013.01 - EP); C07D 263/38 (2013.01 - EP); C07K 14/75 (2013.01 - EP); C07K 16/2839 (2013.01 - EP); C07K 16/2848 (2013.01 - EP); C12N 9/6491 (2013.01 - EP); C07C 2602/42 (2017.05 - EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9745137 A1 19971204; WO 9745137 A8 20010201; AT E470450 T1 20100615; BR 9709514 A 19990810; CA 2256543 A1 19971204; CA 2256543 C 20101207; CA 2256588 A1 19971204; CN 1226254 A 19990818; CZ 380098 A3 19990512; CZ 383498 A3 19990512; DE 69739907 D1 20100722; DK 0951295 T3 20100913; EP 0907661 A1 19990414; EP 0907661 A4 20000726; EP 0951295 A1 19991027; EP 0951295 A4 20000726; EP 0951295 B1 20100609; HU P9901628 A2 19990830; HU P9901628 A3 20021128; HU P9902099 A2 19990928; HU P9902099 A3 20011029; JP 2002515036 A 20020521; KR 20000016301 A 20000325; KR 20000016302 A 20000325; NO 985574 D0 19981127; NO 985574 L 19990201; NO 985575 D0 19981127; NO 985575 L 19990201; PL 330240 A1 19990510; PL 330241 A1 19990510; WO 9745447 A1 19971204
DOCDB simple family (application)
US 9709158 W 19970530; AT 97928698 T 19970530; BR 9709514 A 19970530; CA 2256543 A 19970530; CA 2256588 A 19970530; CN 97196818 A 19970530; CZ 380098 A 19970530; CZ 383498 A 19970530; DE 69739907 T 19970530; DK 97928698 T 19970530; EP 97927814 A 19970530; EP 97928698 A 19970530; HU P9901628 A 19970530; HU P9902099 A 19970530; JP 54291497 A 19970530; KR 19980709874 A 19981130; KR 19980709875 A 19981130; NO 985574 A 19981127; NO 985575 A 19981127; PL 33024097 A 19970530; PL 33024197 A 19970530; US 9709099 W 19970530